Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Nedaplatin-based concurrent chemoradiotherapy (CCRT) regimen at 2 years was noninferior to cisplatin-based regimen in patients with locoregional, stage II to IVB nasopharyngeal carcinoma (NPC) and was associated with fewer late adverse events, but longer-term outcomes and toxicity are un...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Qing-Nan, Liu, Li-Ting, Qi, Bin, Guo, Shan-Shan, Luo, Dong-Hua, Sun, Rui, Sun, Xue-Song, Chen, Dong-Ping, Guo, Ling, Mo, Hao-Yuan, Wang, Pan, Liu, Sai-Lan, Liang, Yu-Jing, Li, Xiao-Yun, Yang, Zhen-Chong, Chen, Qiu-Yan, Mai, Hai-Qiang, Tang, Lin-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689390/
https://www.ncbi.nlm.nih.gov/pubmed/34928359
http://dx.doi.org/10.1001/jamanetworkopen.2021.38470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689390/
https://www.ncbi.nlm.nih.gov/pubmed/34928359
http://dx.doi.org/10.1001/jamanetworkopen.2021.38470

Ejemplares similares